Livzon Pharmaceutical Group Inc (000513) — Free Cash Flow Generation Index
Livzon Pharmaceutical Group Inc (000513) has a Free Cash Flow Generation Index of 0.87x as of September 2025. Free cash flow of CN¥744.93 Million represents 1% of operating cash flow (CN¥853.59 Million). See Livzon Pharmaceutical Group Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Livzon Pharmaceutical Group Inc Free Cash Flow Generation Index (1999–2024)
Historical FCF Generation Index trend for Livzon Pharmaceutical Group Inc across 26 annual periods. Explore cash flow to debt ratio of Livzon Pharmaceutical Group Inc to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Livzon Pharmaceutical Group Inc (1999–2024)
Year-by-year Free Cash Flow Generation Index for Livzon Pharmaceutical Group Inc. For the full company profile including market capitalisation, see 000513 market cap overview.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.81x | CN¥2.41 Billion | CN¥2.98 Billion | CN¥570.16 Million | ▲ +13.0% |
| 2023 | 0.72x | CN¥2.43 Billion | CN¥3.39 Billion | CN¥820.45 Million | ▲ +8.3% |
| 2022 | 0.66x | CN¥1.83 Billion | CN¥2.77 Billion | CN¥940.15 Million | ▲ +111.9% |
| 2021 | 0.31x | CN¥593.23 Million | CN¥1.90 Billion | CN¥1.31 Billion | ▼ -55.5% |
| 2020 | 0.70x | CN¥1.51 Billion | CN¥2.16 Billion | CN¥646.98 Million | ▼ -9.6% |
| 2019 | 0.77x | CN¥1.37 Billion | CN¥1.77 Billion | CN¥398.00 Million | ▲ +23.8% |
| 2018 | 0.63x | CN¥793.15 Million | CN¥1.27 Billion | CN¥474.47 Million | ▼ -19.4% |
| 2017 | 0.78x | CN¥1.02 Billion | CN¥1.32 Billion | CN¥294.15 Million | ▲ +9.1% |
| 2016 | 0.71x | CN¥910.76 Million | CN¥1.28 Billion | CN¥368.46 Million | ▲ +46.6% |
| 2015 | 0.49x | CN¥450.65 Million | CN¥927.79 Million | CN¥477.13 Million | ▲ +571.7% |
| 2014 | 0.07x | CN¥51.87 Million | CN¥717.39 Million | CN¥665.52 Million | ▲ +106.6% |
| 2013 | -1.09x | CN¥-480.01 Million | CN¥439.99 Million | CN¥920.00 Million | ▼ -284.9% |
| 2012 | -0.28x | CN¥-168.34 Million | CN¥593.96 Million | CN¥762.30 Million | ▼ -155.9% |
| 2011 | 0.51x | CN¥359.37 Million | CN¥708.20 Million | CN¥348.83 Million | ▲ +8.4% |
| 2010 | 0.47x | CN¥296.34 Million | CN¥633.30 Million | CN¥336.95 Million | ▼ -36.3% |
| 2009 | 0.73x | CN¥363.47 Million | CN¥494.88 Million | CN¥131.41 Million | ▼ -6.0% |
| 2008 | 0.78x | CN¥269.66 Million | CN¥345.18 Million | CN¥75.52 Million | ▲ +23.5% |
| 2007 | 0.63x | CN¥157.28 Million | CN¥248.55 Million | CN¥91.28 Million | ▲ +211.4% |
| 2006 | 0.20x | CN¥46.01 Million | CN¥226.46 Million | CN¥180.45 Million | ▲ +134.2% |
| 2005 | -0.59x | CN¥-95.65 Million | CN¥161.07 Million | CN¥256.72 Million | ▼ -408.0% |
| 2004 | 0.19x | CN¥34.98 Million | CN¥181.46 Million | CN¥146.48 Million | ▼ -70.6% |
| 2003 | 0.65x | CN¥196.45 Million | CN¥300.01 Million | CN¥103.56 Million | ▲ +27.1% |
| 2002 | 0.52x | CN¥110.03 Million | CN¥213.65 Million | CN¥103.62 Million | ▲ +8.5% |
| 2001 | 0.47x | CN¥73.66 Million | CN¥155.15 Million | CN¥81.48 Million | ▲ +179.6% |
| 2000 | -0.60x | CN¥-22.98 Million | CN¥38.52 Million | CN¥61.49 Million | ▼ -185.0% |
| 1999 | 0.70x | CN¥172.78 Million | CN¥246.23 Million | CN¥73.44 Million | — |